Key result
Low molecular weight heparin resulted in 0% deep vein thrombosis compared to 2.2% with heparin calcium, and avoided severe hemorrhages that caused 5 control patients to suspend treatment.
Why the study?
Does low molecular weight heparin prevent post-surgical deep vein thrombosis and pulmonary embolism more safely than unfractionated heparin in patients undergoing abdominal surgery?
Does low molecular weight heparin prevent post-surgical deep vein thrombosis and pulmonary embolism more safely than unfractionated heparin in patients undergoing abdominal surgery?
Answers are grounded in this paper and cite their sources.
Low molecular weight heparin is as effective as unfractionated heparin for preventing deep vein thrombosis after abdominal surgery, but demonstrates a superior safety profile with fewer severe bleeding events.
An open controlled study was carried out to assess the efficacy and tolerance of a new low molecular weight heparin for the prevention of post-surgical deep vein thrombosis and pulmonary embolism. Forty-five patients undergoing abdominal surgery mainly for neoplasm, gallstones and gastric ulcers were administered 7,500 AXaU of low molecular weight heparin subcutaneously, 2 hours before surgery and once a day for 7 days after. Heparin calcium (15,000 IU subcutaneously per day) was used as a comparison drug in 45 control subjects, matched for age, sex and type of operation. Deep vein thrombosis was identified with clinical parameters, radio-labelled fibrinogen uptake test, echo-doppler and venography; pulmonary embolism with clinical examination, chest X-rays and/or scintigraphy. No episodes of deep vein thrombosis occurred in the low molecular weight heparin-treated patients, whilst there was 1 episode, without pulmonary embolism, in the control group. The consumption of blood and haemoderivatives for transfusions was higher in the heparin calcium group. Only in this group, furthermore, did 5 patients have to suspend antithrombotic treatment due to severe haemorrhages. General tolerance of the two drugs was identical and very good.
No takes yet. Share an insight, caveat, or question.
Garcea et al. (1992) studied Abdominal surgery (n=90). Low molecular weight heparin vs. Heparin calcium (15,000 IU subcutaneously per day) was evaluated on Deep vein thrombosis. Low molecular weight heparin resulted in 0% deep vein thrombosis compared to 2.2% with heparin calcium, and avoided severe hemorrhages that caused 5 control patients to suspend treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: